Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
PODCAST | First void urine: revolutionizing potential non-invasive biomarker collection for clinical diagnostics LISTEN NOW

BZ 2024 wrapped

8 Jan 2025
Antibodies | ADCs Automation Biomarkers Cell and gene therapies Chromatography Clinical Drug development Expert opinion General interest Interviews MS (LC–MS/MS, HRMS, IMS) News Oligonucleotides

2024 was quite the year for the bioanalytical community. For this year’s summary, we’ve put together a new and exclusive feature to say thank you for your continued support as our audience. Check out our mood board below, offering a visual summary of the year’s top bioanalysis content.

Simply zoom in and click on your favorite features to find out more!

BZ 2024 WRAPPED (2)

Top content

  • Real-time liquid biopsy study aims to transform cancer treatment monitoring

Related tags

2024 wrapped bioanalysis
Previous article

Related articles

30 JAN 2018 BIOANALYSIS RISING STAR AWARD
Bioanalysis Rising Star Award Judging Panel: Laura Mercolini
5 MAR 2018 INTERVIEWS
International Women’s Day: A day in the life of…Lieve Dillen
10 MAY 2023 JOURNAL ARTICLES
Non-regulated LC–MS/MS bioanalysis in support of early drug development: a Novartis perspective
25 JAN 2019 BIOANALYSIS RISING STAR AWARD
Bioanalysis Rising Star Award: meet the judges
4 APR 2018 GENERAL INTEREST
Application of DMS in boosting sensitivity for protein digest LC–MS/MS workflow
4 JAN 2018 NEWS
Bioanalysis volume 10, issue 1
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone